Let us know A major pharmaceutical company is leaving behind more than half a million square feet in a suburb of Washington, D.C. when its lease expires next year. London-based GSK is set to ...

The company (NYSE: GSK) said it will leave the office and lab complex at 14200 Shady Grove Road when its lease is up in June 2026. Employees will remain there through March 2026. London-based GSK ...

The letter was shared with The Washington Post ... Hassan sent the letter to GSK after her office was contacted by the New England Pediatric Pulmonary Consortium. The pulmonologists said GSK ...

GSK is also working with SK Bioscience on a phase 1/2 study for a vaccine based on self-assembling nanoparticle technology developed by the University of Washington, with funding from CEPI and the ...